Machine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and Intensification

dc.contributor.authorOzdede, Murat
dc.contributor.authorGuven, Alper T.
dc.contributor.pubmedID38274913en_US
dc.date.accessioned2024-04-03T08:11:42Z
dc.date.available2024-04-03T08:11:42Z
dc.date.issued2023
dc.description.abstractBackground Elevated serum uric acid, associated with cardiovascular conditions such as atherosclerotic heart disease, hypertension, and heart failure, can be elevated by thiazide or thiazide-like drugs (THZ), essential in hypertension management. Identifying clinical determinants affecting THZ-related uric acid elevation is critical. Methods In this retrospective cross-sectional study, we explored the clinical determinants influencing uric acid elevation related to THZ, focusing on patients where THZ was initiated or the dose escalated. A cohort of 143 patients was analyzed, collecting baseline and control uric acid levels, alongside basic biochemical studies and clinical data. Feature selection was conducted utilizing criteria based on mean squared error increase and enhancement in node purity. Four machine learning algorithms - Random Forest, Neural Network, Support Vector Machine, and Gradient Boosting regressions - were applied to pinpoint clinical influencers. Results Significant features include uncontrolled diabetes, index estimated Glomerular Filtration Rate (eGFR) level, absence of insulin, action of indapamide, and absence of statin treatment, with absence of Sodium -glucose cotransporter 2 inhibitors (SGLT2i), low dose aspirin exposure, and older age also being noteworthy. Among the applied models, the Gradient Boosting regression model outperformed the others, exhibiting the lowest Mean Absolute Error (MAE), Mean Squared Error (MSE), Root Mean Squared Error (RMSE) values, and the highest R2 value (0.779). While Random Forest and Neural Network regression models were able to fit the data adequately, the Support Vector Machine demonstrated inferior metrics. Conclusions Machine learning algorithms are adept at accurately identifying the factors linked to uric acid fluctuations caused by THZ. This proficiency aids in customizing treatments more effectively, reducing the need to unnecessarily avoid THZ, and providing guidance on its use to prevent instances where uric acid levels could become problematic.en_US
dc.identifier.eissn2168-8184en_US
dc.identifier.issue12en_US
dc.identifier.urihttps://assets.researchsquare.com/files/rs-3401602/v1/dbbd50c2-c2b9-4e1a-95b8-680a2ca97175.pdf?c=1700204855
dc.identifier.urihttp://hdl.handle.net/11727/11988
dc.identifier.volume15en_US
dc.identifier.wos001153909300022en_US
dc.language.isoengen_US
dc.relation.isversionof10.7759/cureus.51109en_US
dc.relation.journalCUREUS JOURNAL OF MEDICAL SCIENCEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjecthydrochlorothiazideen_US
dc.subjectindapamideen_US
dc.subjectthiazidesen_US
dc.subjectmachine learningen_US
dc.subjecthyperuricemiaen_US
dc.subjecthypertensionen_US
dc.titleMachine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and Intensificationen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
dbbd50c2-c2b9-4e1a-95b8-680a2ca97175.pdf
Size:
518.31 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: